ALEXANDRA MOORE: Open Payments
NPI 1134645401 · WINDER, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$619 in 30 payments from 22 companies in 2025. Trend: 2023 $437 · 2024 $553 · 2025 $619
Food & beverage: $619
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $63 |
| Xeris Pharmaceuticals, Inc. | 2 | $49 |
| Corcept Therapeutics | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| Novo Nordisk Inc | 2 | $43 |
| Tandem Diabetes Care, Inc. | 2 | $42 |
| Dexcom, Inc. | 2 | $42 |
| Janssen Biotech, Inc. | 1 | $27 |
| Madrigal Pharmaceuticals | 1 | $26 |
| Abbott Laboratories | 1 | $22 |
Products named: KEVEYIS, ZEPBOUND, Korlym, t:slim X2 Insulin Pump with Control-IQ, Dexcom G6 Transmitter, TREMFYA, REZDIFFRA, Rybelsus.
Industry payments across GA — which companies pay providers there.
